304 related articles for article (PubMed ID: 19110623)
21. Applications of Sleeping Beauty transposons for nonviral gene therapy.
Liu H; Visner GA
IUBMB Life; 2007 Jun; 59(6):374-9. PubMed ID: 17613167
[TBL] [Abstract][Full Text] [Related]
22. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
[TBL] [Abstract][Full Text] [Related]
23. Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.
Orbán TI; Apáti A; Németh A; Varga N; Krizsik V; Schamberger A; Szebényi K; Erdei Z; Várady G; Karászi E; Homolya L; Német K; Gócza E; Miskey C; Mátés L; Ivics Z; Izsvák Z; Sarkadi B
Stem Cells; 2009 May; 27(5):1077-87. PubMed ID: 19415778
[TBL] [Abstract][Full Text] [Related]
24. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.
Yant SR; Meuse L; Chiu W; Ivics Z; Izsvak Z; Kay MA
Nat Genet; 2000 May; 25(1):35-41. PubMed ID: 10802653
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral transduction of immune cells.
Swainson L; Mongellaz C; Adjali O; Vicente R; Taylor N
Methods Mol Biol; 2008; 415():301-20. PubMed ID: 18370162
[TBL] [Abstract][Full Text] [Related]
27. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
[TBL] [Abstract][Full Text] [Related]
28. Transposon vectors for gene-trap insertional mutagenesis in vertebrates.
Clark KJ; Geurts AM; Bell JB; Hackett PB
Genesis; 2004 Aug; 39(4):225-33. PubMed ID: 15286994
[TBL] [Abstract][Full Text] [Related]
29. Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.
Romano G; Marino IR; Pentimalli F; Adamo V; Giordano A
Drug News Perspect; 2009 May; 22(4):185-96. PubMed ID: 19536363
[TBL] [Abstract][Full Text] [Related]
30. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.
Micucci F; Zingoni A; Piccoli M; Frati L; Santoni A; Galandrini R
Exp Hematol; 2006 Oct; 34(10):1344-52. PubMed ID: 16982327
[TBL] [Abstract][Full Text] [Related]
31. Transposable elements for transgenesis and insertional mutagenesis in vertebrates: a contemporary review of experimental strategies.
Ivics Z; Izsvák Z
Methods Mol Biol; 2004; 260():255-76. PubMed ID: 15020812
[TBL] [Abstract][Full Text] [Related]
32. Current development of lentiviral-mediated gene transfer.
Romano G
Drug News Perspect; 2005 Mar; 18(2):128-34. PubMed ID: 15883621
[TBL] [Abstract][Full Text] [Related]
33. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Hacein-Bey-Abina S; Von Kalle C; Schmidt M; McCormack MP; Wulffraat N; Leboulch P; Lim A; Osborne CS; Pawliuk R; Morillon E; Sorensen R; Forster A; Fraser P; Cohen JI; de Saint Basile G; Alexander I; Wintergerst U; Frebourg T; Aurias A; Stoppa-Lyonnet D; Romana S; Radford-Weiss I; Gross F; Valensi F; Delabesse E; Macintyre E; Sigaux F; Soulier J; Leiva LE; Wissler M; Prinz C; Rabbitts TH; Le Deist F; Fischer A; Cavazzana-Calvo M
Science; 2003 Oct; 302(5644):415-9. PubMed ID: 14564000
[TBL] [Abstract][Full Text] [Related]
34. Surface-engineering of lentiviral vectors.
Verhoeyen E; Cosset FL
J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
[TBL] [Abstract][Full Text] [Related]
35. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.
Themis M; Waddington SN; Schmidt M; von Kalle C; Wang Y; Al-Allaf F; Gregory LG; Nivsarkar M; Themis M; Holder MV; Buckley SM; Dighe N; Ruthe AT; Mistry A; Bigger B; Rahim A; Nguyen TH; Trono D; Thrasher AJ; Coutelle C
Mol Ther; 2005 Oct; 12(4):763-71. PubMed ID: 16084128
[TBL] [Abstract][Full Text] [Related]
36. Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells.
Parveen Z; Krupetsky A; Engelstädter M; Cichutek K; Pomerantz RJ; Dornburg R
Nat Biotechnol; 2000 Jun; 18(6):623-9. PubMed ID: 10835599
[TBL] [Abstract][Full Text] [Related]
37. Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics.
Barsov EV; Andersen H; Coalter VJ; Carrington M; Lifson JD; Ott DE
Immunol Lett; 2006 May; 105(1):26-37. PubMed ID: 16442639
[TBL] [Abstract][Full Text] [Related]
38. Efficient gene transfer into human monocyte-derived macrophages using defective lentiviral vectors.
Lu Y; Liu C; Zeng L; Lin Z; Dewhurst S; Gartner S; Planelles V
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1151-6. PubMed ID: 14682398
[TBL] [Abstract][Full Text] [Related]
39. Design of a nonviral vector for site-selective, efficient integration into the human genome.
Kaminski JM; Huber MR; Summers JB; Ward MB
FASEB J; 2002 Aug; 16(10):1242-7. PubMed ID: 12153992
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
